A METHOD OF REDUCING ACRYLAMIDE IN COFFEE EXTRACT AND A SOLUBLE COFFEE PRODUCT

20240008505 ยท 2024-01-11

    Inventors

    Cpc classification

    International classification

    Abstract

    The present invention provides a method of reducing acrylamide in an aqueous coffee extract, the method comprising: contacting an acrylamide-containing aqueous coffee extract with spent coffee grounds at a temperature of 70 to 120 C. for at least 30 minutes to form an acrylamide-depleted coffee extract.

    Claims

    1. A method of reducing acrylamide in an aqueous coffee extract, the method comprising: contacting an acrylamide-containing aqueous coffee extract with spent coffee grounds at a temperature of 70 to 120 C. for at least 30 minutes to form an acrylamide-depleted coffee extract.

    2. A method according to claim 1, wherein before being contacted with the spent coffee grounds the aqueous coffee extract comprises at least 5 ppm acrylamide.

    3. A method according to claim 1, wherein the acrylamide-depleted coffee extract comprises less than 400 ppb acrylamide.

    4. A method according to claim 1, wherein the method reduces the acrylamide levels by at least 30%.

    5. A method according to claim 1, wherein the acrylamide-containing aqueous coffee extract is contacted with the spent coffee grounds at a temperature of from 100 to 120 C.

    6. A method according to claim 1, wherein the acrylamide-containing aqueous coffee extract is contacted with the spent coffee grounds for from 1 to 50 hours.

    7. A method according to claim 1, wherein the spent coffee grounds are provided as a waste product following aqueous extraction of roast and ground coffee at a temperature of at least 175 C.

    8. A method according to claim 1, wherein the acrylamide-containing aqueous coffee extract is passed through the spent coffee grounds in a continuous process.

    9. A method according to claim 1, wherein the acrylamide-containing aqueous coffee extract comprises from 1 to 55 wt % soluble coffee solids.

    10. A method according to claim 1, wherein the spent coffee grounds are provided as a bed of spent coffee grounds.

    11. A method according to claim 10, wherein the bed of spent coffee is held in a sealed pressure chamber.

    12. A method of producing a soluble coffee product, the method comprising: providing spent coffee grounds; providing roasted and ground coffee beans; performing an aqueous extraction of the roasted and ground coffee beans at a temperature of from 175 to 220 C., to obtain an acrylamide-containing aqueous coffee extract; performing the method according to claim 1 using the spent coffee grounds to obtain the acrylamide-depleted coffee extract; drying the acrylamide-depleted coffee extract to provide a soluble coffee product.

    13. A method according to claim 12, wherein the step of drying is a step of spray-drying or a step of freeze-drying.

    14. A method according to claim 1, wherein the acrylamide-containing aqueous coffee extract is contacted with the spent coffee grounds for from 2 to 10 hours.

    15. A method according to claim 12, wherein the step of performing an aqueous extraction of the roasted and ground coffee beans is at a temperature of from 175 to 205 C.

    Description

    [0050] The invention will now be described further with reference to the following non-limiting figures, in which:

    [0051] FIG. 1 shows a configuration for a percolation bed with optional recirculation for contacting aqueous coffee extract with spent coffee grounds; and

    [0052] FIG. 2 shows a slurry treatment system for contacting aqueous coffee extract with spent coffee grounds.

    [0053] The invention will now be described further with reference to the following non-limiting examples.

    [0054] Aqueous coffee extracts obtained by a three stage extraction process, including a final aqueous extraction step at around 200 C. were held in contact with spent coffee grounds and their levels of acrylamide were measured before and after treatment. The reduction observed is summarised in the table below. The normalised level is based on the starting level of acrylamide being set to 1.

    TABLE-US-00001 Treatment Temperature Holding Normalised ( C.) time (hrs) Acrylamide Level 120 1 0.18 120 3 0.05 70 3 0.58 70 50 0.39 37 400 0.85 37 750 0.85 37 1100 0.68 37 1450 0.52 23 400 0.92 23 750 0.92 23 1100 0.89 23 1450 0.76

    [0055] As can be seen, acrylamide levels dropped for all tested samples, but only within the range of 70 to 120 C. were the treatment times within commercially viable durations.

    [0056] Although preferred embodiments of the invention have been described herein in detail, it will be understood by those skilled in the art that variations may be made thereto without departing from the scope of the invention or of the appended claims.